Skye Bioscience, Inc. (SKYE) bonds
SKYENasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 3/30
$1.06−0.03 (-2.29%)
Close on Nov 16, 2026Market cap $37.72MP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Skye Bioscience reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in Skye Bioscience's 10-K for the period ended Dec 31, 2024
Skye Bioscience's filings do not break debt down by note
The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size |
|---|---|
| Convertible 10% Note | $5.00M |
See a number that looks wrong?